Insider · CIK 0001754632
Jennifer Yoss
Files at CRVL (CORVEL CORP). First filing Feb 10, 2025, latest May 27, 2026.
Jennifer Yoss files SEC Form 4 as officer at CRVL (CORVEL CORP). Since Feb 10, 2025, Jennifer Yoss has reported 0 open-market buys worth $0 and 3 open-market sells worth $489k, the latest filed on May 27, 2026.
A track record needs three past buys with six months of prices behind them; Jennifer Yoss has 0, so none is measured yet.
The newest scored trade: sold $122k of CRVL on May 26, 2026, filed May 27, 2026, scored 45 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $122k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRVL: CORVEL CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | CORVEL CORP | $122k 1,999 shares | -64% | +33% from low-46% from high | |
| 35Weak | CORVEL CORP | $117k 1,050 shares | -33% | +12% from low-14% from high | |
| 48Moderate | CORVEL CORP | $250k 1,995 shares | -60% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 29, 2025 | CRVL CORVEL CORPORATION | 1,050 0.00% of outstanding | $117k | May 29, 2025 | none |
| Feb 6, 2025 | CRVL CORVEL CORP | 2,142 0.00% of outstanding | $267k | Feb 6, 2025 | none |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | CRVL CORVEL CORP | AGrant or award Common Stock | +36 | $70.82 | $2,550 | 2,209 | 12 d ago |
| May 26, 2026 | CRVL CORVEL CORP | MOption exercise Common Stock | +958 | $52.00 | $50k | 3,131 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | SOpen-market sale Common Stock | -958 | $61.02 | $58k | 2,173 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | MOption exercise Common Stock | +141 | $52.00 | $7,332 | 2,314 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | SOpen-market sale Common Stock | -141 | $61.02 | $8,604 | 2,173 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | MOption exercise Common Stock | +900 | $49.63 | $45k | 3,073 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | SOpen-market sale Common Stock | -900 | $61.02 | $55k | 2,173 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -900 | $0.00 | $0 | 0 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -958 | $0.00 | $0 | 2,241 | May 27, 2026 |
| May 26, 2026 | CRVL CORVEL CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -141 | $0.00 | $0 | 2,100 | May 27, 2026 |
| Mar 31, 2026 | CRVL CORVEL CORP | AGrant or award Common Stock | +50 | $51.92 | $2,596 | 2,173 | Apr 2, 2026 |
| Mar 4, 2026 | CRVL CORVEL CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,500 | $0.00 | $0 | 3,500 | Mar 6, 2026 |
| Nov 6, 2025 | CRVL CORVEL CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,500 | $0.00 | $0 | 3,500 | Nov 10, 2025 |
| Sep 30, 2025 | CRVL CORVEL CORP | AGrant or award Common Stock | +35 | $73.55 | $2,574 | 2,123 | Oct 1, 2025 |
| May 29, 2025 | CRVL CORVEL CORP | MOption exercise Common Stock | +1,050 | $39.83 | $42k | 3,138 | May 30, 2025 |
| May 29, 2025 | CRVL CORVEL CORP | SOpen-market sale Common Stock | -1,050 | $111.39 | $117k | 2,088 | May 30, 2025 |
| May 29, 2025 | CRVL CORVEL CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -1,050 | $0.00 | $0 | 0 | May 30, 2025 |
| May 15, 2025 | CRVL CORVEL CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +450 | $0.00 | $0 | 450 | May 19, 2025 |
| Mar 31, 2025 | CRVL CORVEL CORP | AGrant or award Common Stock | +24 | $106.37 | $2,553 | 2,088 | Apr 2, 2025 |
| Feb 6, 2025 | CRVL CORVEL CORP | MOption exercise Common Stock | +1,272 | $65.72 | $84k | 3,336 | Feb 10, 2025 |
| Feb 6, 2025 | CRVL CORVEL CORP | SOpen-market sale Common Stock | -1,272 | $125.54 | $160k | 2,064 | Feb 10, 2025 |
| Feb 6, 2025 | CRVL CORVEL CORP | MOption exercise Common Stock | +723 | $65.72 | $48k | 2,787 | Feb 10, 2025 |
| Feb 6, 2025 | CRVL CORVEL CORP | SOpen-market sale Common Stock | -723 | $125.54 | $91k | 2,064 | Feb 10, 2025 |
| Feb 6, 2025 | CRVL CORVEL CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -1,272 | $0.00 | $0 | 3,675 | Feb 10, 2025 |
| Feb 6, 2025 | CRVL CORVEL CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -723 | $0.00 | $0 | 2,952 | Feb 10, 2025 |
| Jan 14, 2025 | CRVL CORVEL CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | Jan 16, 2025 |
Questions about Jennifer Yoss
Answered from the filings on this page, as of the latest one.
Is Jennifer Yoss buying or selling?
In the last 12 months Jennifer Yoss reported 0 open-market buys worth $0 and 1 open-market sell worth $122k on SEC Form 4; the latest was sold $122k of CRVL on May 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Jennifer Yoss's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer Yoss has 0.
Where does Jennifer Yoss file Form 4?
Jennifer Yoss has filed Form 4 at CRVL (CORVEL CORP) as Vice President of Accounting. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.